Le Jeune Puetz Investment Counsel LLC Biogen Inc. Transaction History
Le Jeune Puetz Investment Counsel LLC
- $272 Million
- Q1 2023
A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Biogen Inc. stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 452 shares of BIIB stock, worth $78,214. This represents 0.05% of its overall portfolio holdings.
Number of Shares
452
Previous 452
-0.0%
Holding current value
$78,214
Previous $125,000
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding BIIB
# of Institutions
1,014Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.87 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.82 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.52 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.23 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$983 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $24.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...